Pharmacokinetics of pentoxifylline after oral administration of a sustained release tablet at two different times of the day

被引:0
|
作者
Srinivasu, P [1 ]
Rambhau, D [1 ]
Rao, BR [1 ]
Rao, YM [1 ]
机构
[1] Kakatiya Univ, Univ Coll Pharmaceut Sci, Warangal 506009, Andhra Pradesh, India
来源
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 1999年 / 49卷 / 09期
关键词
CAS; 6493-05-6; pentoxifylline; Trental; (R); circadian variations; healthy volunteers; pharmacokinetics; sustained release tablet;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pharmacokinetics of pentoxifylline (CAS-6493-05-6) was studied in healthy subjects by orally administering a 400 mg sustained release tablet (Trental(R)) at two different times (10:00 or 22:00 h) of the day in a crossover design. Pentoxifylline concentrations in serum samples were estimated by using high performance liquid chromatography. The mean values of C-max (326.38 +/- 39.77 vs 266.35 +/- 36.0 ng/ml, p < 0.01, n = 8), AUC(0-t) (2424 +/- 382 vs 2141 +/- 300 ng/ml/h, p < 0.05, n = 8) were significantly higher and V-ss/f (16537 +/- 2869 vs 20136 +/- 5006 ml/kg), v(d)/f (11807 +/- 2704 vs 15801 +/- 5960 ml/kg) were significantly (p < 0.05, n = 8) lower following morning (10:00 h) administration than in the night (22:00 h). These variations should be considered while designing sustained release dosage forms.
引用
收藏
页码:750 / 753
页数:4
相关论文
共 50 条
  • [21] Pharmacokinetics of pentoxifylline and its 5-hhdroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses
    Liska, Dana A.
    Akucewich, Lisa H.
    Marsella, Rosanna
    Maxwell, Lara K.
    Barbara, Joanna E.
    Cole, Cynthia A.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2006, 67 (09) : 1621 - 1627
  • [22] Population Pharmacokinetics of the 5-Hydroxymethyl Metabolite of Tolterodine After Administration of Fesoterodine Sustained Release Tablet in Western and East Asian Populations
    Oishi, Masayo
    Tomono, Yoshiro
    Yamagami, Hidetomi
    Malhotra, Bimal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 928 - 936
  • [23] PHARMACOKINETICS OF SUSTAINED-RELEASE KETOPROFEN AFTER DAILY ADMINISTRATION IN ELDERLY SUBJECTS
    ROUX, A
    KLEIN, C
    DUCREUSET, C
    GOBERT, C
    ADVENIER, C
    FRYDMAN, A
    FLOUVAT, B
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 45 (03): : 435 - 446
  • [24] PHARMACOKINETICS OF NITROGLYCERIN AND ITS METABOLITES AFTER ADMINISTRATION OF SUSTAINED-RELEASE TABLETS
    KWON, HR
    GREEN, P
    CURRY, SH
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1992, 13 (02) : 141 - 152
  • [25] Coated hydralazine hydrochloride beads for sustained release after oral administration
    Mughal, M. Akhlaq
    Saripella, Kalyan K.
    Kouba, Chahinaz
    Iqbal, Zafar
    Neau, Steven H.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (09) : 1439 - 1446
  • [26] Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog
    M. Giorgi
    U. Prise
    G. Soldani
    D. Neri
    E. Lavy
    Veterinary Research Communications, 2010, 34 : 73 - 77
  • [27] Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog
    Giorgi, M.
    Prise, U.
    Soldani, G.
    Neri, D.
    Lavy, E.
    VETERINARY RESEARCH COMMUNICATIONS, 2010, 34 : S73 - S77
  • [28] PHARMACOKINETICS OF THEOPHYLLINE IN BEAGLE DOGS AND ASTHMATIC-PATIENTS AFTER MULTIPLE ORAL DOSES OF SUSTAINED-RELEASE THEOPHYLLINE TABLET FORMULATION
    NOSAKA, H
    TAKAGI, K
    HASEGAWA, T
    OGURA, Y
    MIZUKAMI, Y
    SATAKE, T
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1986, 24 (10) : 528 - 535
  • [29] Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects
    Cardot, JM
    Chaumont, C
    Dubray, C
    Costantini, D
    Aiache, JM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 345 - 351
  • [30] Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration
    Wangemann, M
    Retzow, A
    Evers, G
    Mazur, D
    Schug, B
    Blume, H
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (12): : 1131 - 1137